BioSpring and Phenion receive BMBF-Funding for the development of a bioactive for skin treatment
05-Aug-2005 -
The Frankfurt-based Biotech companies BioSpring GmbH and Phenion GmbH & Co. KG receive public funding of approximately 1 million Euro within the "BioChancePlus" funding program of the German Federal Ministry of Education and Research (BMBF). The objective of the common research project is the ...
acids
education
oligonucleotides
+1